Sanmina (SANM) 10-Q 2 Aug 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information Document - $ / shares	9 Months Ended
	Jul. 01, 2023	Jul. 26, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jul. 01, 2023
Document Transition Report	false
Entity File Number	0-21272
Entity Registrant Name	Sanmina Corporation
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	77-0228183
Entity Address, Address Line One	2700 N. First St.,
Entity Address, City or Town	San Jose,
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	95134
City Area Code	(408)
Local Phone Number	964-3500
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Shell Company	false
Title of 12(b) Security	Common Stock
Trading Symbol	SANM
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		57,226,949
Entity Listing, Par Value Per Share	$ 0.01
Entity Central Index Key	0000897723
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--09-30
Entity Emerging Growth Company	false
Entity Small Business	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Current assets:
Cash and cash equivalents	$ 656,588	$ 529,857
Accounts and Other Receivables, Net, Current	1,279,966	1,138,894
Contract assets	459,145	475,721
Inventories	1,489,200	1,684,099
Prepaid expenses and other current assets	68,121	62,044
Total current assets	3,953,020	3,890,615
Property, plant and equipment, net	631,744	575,170
Deferred tax assets	187,434	209,554
Other	185,694	160,192
Total assets	4,957,892	4,835,531
Current liabilities:
Accounts payable	1,724,034	2,041,434
Accrued liabilities	277,515	281,599
Accrued payroll and related benefits	138,815	130,892
Short-term debt, including current portion of long-term debt	17,500	17,500
Total current liabilities	2,157,864	2,471,425
Long-term liabilities:
Long-term debt	316,552	329,237
Other	217,748	215,333
Total long-term liabilities	534,300	544,570
Contingencies (Note 8)
Stockholders’ equity	2,265,728	1,819,536
Total liabilities and stockholders’ equity	$ 4,957,892	$ 4,835,531

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Net sales	$ 2,207,118	$ 2,023,361	$ 6,883,029	$ 5,694,757
Cost of sales	2,023,910	1,861,176	6,313,246	5,244,780
Gross profit	183,208	162,185	569,783	449,977
Operating expenses:
Selling, general and administrative	68,828	61,506	192,948	184,798
Research and development	6,719	5,071	18,712	15,320
Restructuring and other	296	3,994	1,731	3,730
Total operating expenses	75,843	70,571	213,391	203,848
Operating income	107,365	91,614	356,392	246,129
Interest income	4,213	540	9,685	1,198
Interest expense	(10,066)	(5,615)	(28,033)	(15,362)
Other expense	(2,508)	(7,774)	(11,988)	(7,110)
Interest and other, net	(8,361)	(12,849)	(30,336)	(21,274)
Income before income taxes	99,004	78,765	326,056	224,855
Provision for income taxes	17,267	1,543	63,898	42,835
Net income before noncontrolling interest	81,737	77,222	262,158	182,020
Less: Net income attributable to noncontrolling interest	5,243	0	14,029	0
Net income attributable to common shareholders	$ 76,494	$ 77,222	$ 248,129	$ 182,020
Net income attributable to common shareholders per share:
Basic	$ 1.32	$ 1.29	$ 4.28	$ 2.92
Diluted	$ 1.28	$ 1.25	$ 4.14	$ 2.83
Weighted average shares used in computing per share amounts:
Basic	57,987	59,970	57,995	62,404
Diluted	59,592	61,702	59,996	64,292
Parent
Operating expenses:
Net income attributable to common shareholders	$ 76,494	$ 77,222	$ 248,129	$ 182,020

Condensed Consolidated Statem_2

Condensed Consolidated Statement of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Net income before noncontrolling interest	$ 81,737	$ 77,222	$ 262,158	$ 182,020
Other comprehensive income (loss), net of tax:
Change in foreign currency translation adjustments	(436)	(3,819)	6,807	(6,935)
Derivative financial instruments:
Change in net unrealized amount	6,856	(2,497)	14,263	7,243
Amount reclassified into net income before noncontrolling interest	(1,832)	5,351	(11,331)	7,751
Defined benefit plans:
Changes in unrecognized net actuarial losses and unrecognized transition costs	(58)	719	(966)	1,380
Amortization of actuarial losses and transition costs	222	228	784	708
Total other comprehensive income (loss), net of tax	4,752	(18)	9,557	10,147
Comprehensive income before noncontrolling interest	86,489	77,204	271,715	192,167
Less: Net income attributable to noncontrolling interest	5,243	0	14,029	0
Comprehensive income attributable to common shareholders	$ 81,246	$ 77,204	$ 257,686	$ 192,167

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Stockholder's Equity Statement - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock and Additional Paid in Capital	Treasury Stock, Common	Accumulated Other Comprehensive Income	Accumulated Deficit	Parent	Noncontrolling Interest [Member]	Number of Common Shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares			44,427
Balance at Oct. 02, 2021		$ 6,339,506	$ (1,047,202)	$ 40,690	$ (3,480,362)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, Value		1,474
Stock-based compensation expense		29,045
Adjustments to Additional Paid in Capital, Other		(144)
APIC Sale of Noncontrolling Interest		0
Repurchases of Treasury Stock, Value			$ 306,614
Other comprehensive income (loss)				10,147
Net income attributable to common shareholders	$ 182,020					$ 182,020
Noncontrolling Interest in Joint Ventures at Oct. 02, 2021							$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Noncontrolling Interest, Increase from Sale of Parent Equity Interest							0
Less: Net income attributable to noncontrolling interest	0						0
Noncontrolling Interest in Joint Ventures at Jul. 02, 2022							0
Common Stock, Shares, Issued at Oct. 02, 2021								108,734
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, shares								1,276
Common Stock, Shares, Issued at Jul. 02, 2022								110,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of treasury stock			(7,793)
Balance at Jul. 02, 2022		6,369,881	$ (1,353,816)	50,837	(3,298,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares			49,124
Balance at Apr. 02, 2022		6,359,270	$ (1,229,523)	50,855	(3,375,564)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, Value		72
Stock-based compensation expense		10,683
Adjustments to Additional Paid in Capital, Other		(144)
APIC Sale of Noncontrolling Interest		0
Repurchases of Treasury Stock, Value			$ 124,293
Other comprehensive income (loss)				(18)
Net income attributable to common shareholders	77,222					77,222
Noncontrolling Interest in Joint Ventures at Apr. 02, 2022							0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Noncontrolling Interest, Increase from Sale of Parent Equity Interest							0
Less: Net income attributable to noncontrolling interest	0						0
Noncontrolling Interest in Joint Ventures at Jul. 02, 2022							0
Common Stock, Shares, Issued at Apr. 02, 2022								109,911
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, shares								99
Common Stock, Shares, Issued at Jul. 02, 2022								110,010
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of treasury stock			(3,096)
Balance at Jul. 02, 2022		6,369,881	$ (1,353,816)	50,837	(3,298,342)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders’ equity	1,768,560
Treasury Stock, Common, Shares			52,220
Stockholders’ equity	1,819,536
Treasury Stock, Common, Shares			52,766
Balance at Oct. 01, 2022		6,381,348	$ (1,378,159)	56,325	(3,239,978)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, Value		295
Stock-based compensation expense		37,460
Adjustments to Additional Paid in Capital, Other		0
APIC Sale of Noncontrolling Interest		78,169
Repurchases of Treasury Stock, Value			$ 73,579
Other comprehensive income (loss)				9,557
Net income attributable to common shareholders	248,129					248,129
Noncontrolling Interest in Joint Ventures at Oct. 01, 2022							0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Noncontrolling Interest, Increase from Sale of Parent Equity Interest							132,132
Less: Net income attributable to noncontrolling interest	14,029						14,029
Noncontrolling Interest in Joint Ventures at Jul. 01, 2023							146,161
Common Stock, Shares, Issued at Oct. 01, 2022								110,160
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, shares								1,168
Common Stock, Shares, Issued at Jul. 01, 2023								111,328
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of treasury stock			(1,343)
Balance at Jul. 01, 2023		6,497,272	$ (1,451,738)	65,882	(2,991,849)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, Common, Shares			53,127
Balance at Apr. 01, 2023		6,483,955	$ (1,399,666)	61,130	(3,068,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, Value		0
Stock-based compensation expense		13,317
Adjustments to Additional Paid in Capital, Other		0
APIC Sale of Noncontrolling Interest		0
Repurchases of Treasury Stock, Value			$ 52,072
Other comprehensive income (loss)				4,752
Net income attributable to common shareholders	76,494					$ 76,494
Noncontrolling Interest in Joint Ventures at Apr. 01, 2023							140,918
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Noncontrolling Interest, Increase from Sale of Parent Equity Interest							0
Less: Net income attributable to noncontrolling interest	5,243						5,243
Noncontrolling Interest in Joint Ventures at Jul. 01, 2023							$ 146,161
Common Stock, Shares, Issued at Apr. 01, 2023								111,285
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuances under stock plans, shares								43
Common Stock, Shares, Issued at Jul. 01, 2023								111,328
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Repurchases of treasury stock			(982)
Balance at Jul. 01, 2023		$ 6,497,272	$ (1,451,738)	$ 65,882	$ (2,991,849)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders’ equity	$ 2,265,728
Treasury Stock, Common, Shares			54,109

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022
CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES:
Net income before noncontrolling interest	$ 262,158	$ 182,020
Adjustments to reconcile net income before noncontrolling interest to cash provided by (used in) operating activities:
Depreciation and amortization	87,716	82,097
Stock-based compensation expense	37,460	29,045
Deferred income taxes	21,232	15,993
Other, net	284	(1,298)
Changes in operating assets and liabilities, net of amounts acquired:
Accounts receivable	(137,712)	(40,276)
Contract assets	16,576	(112,606)
Inventories	199,406	(552,851)
Prepaid expenses and other assets	(27,492)	(13,269)
Accounts payable	(308,579)	507,909
Accrued liabilities	7,262	152,192
Cash provided by operating activities	158,311	248,956
CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(153,239)	(90,398)
Proceeds from Sale of Property, Plant, and Equipment	1,084	8,339
Purchases of investments	(2,000)	(1,700)
Cash used in investing activities	(154,155)	(83,759)
CASH FLOWS PROVIDED BY (USED IN) FINANCING ACTIVITIES:
Holdback paid in connection with previous business combination	(8,558)	0
Repayments of long-term debt	(13,125)	(14,064)
Proceeds from revolving credit facility borrowings	2,426,300	926,500
Repayments of revolving credit facility borrowings	(2,426,300)	(926,500)
Net proceeds from stock issuances	295	1,474
Repurchases of common stock including excise tax	73,579
Repurchases of common stock		(306,758)
Proceeds from notes receivable	0	500
Proceeds from sale of noncontrolling interest	215,799	0
Cash provided by (used in) financing activities	120,832	(318,848)
Effect of exchange rate changes	1,743	(3,070)
Increase (decrease) in cash and cash equivalents	126,731	(156,721)
Cash and cash equivalents at beginning of period	529,857	650,026
Cash and cash equivalents at end of period	656,588	493,305
Cash paid during the period for:
Interest, net of capitalized interest	24,908	12,155
Income taxes, net of refunds	45,053	33,801
Unpaid purchases of property, plant and equipment at the end of period	$ 25,938	$ 28,831

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parentheticals) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Accounts Receivable, Allowance for Credit Loss, Current	$ 8,000	$ 8,000

Note 1. Restatement of Condense

Note 1. Restatement of Condensed Consolidated Financial Statements	9 Months Ended
	Jul. 01, 2023
Accounting Changes and Error Corrections [Abstract]
Error Correction	Restatement of Condensed Consolidated Financial Statements Sanmina Corporation (the “Company” or “Sanmina”) identified misstatements in the unaudited condensed consolidated financial statements for the comparative periods of 2022 in conjunction with an independent investigation conducted by the Audit Committee of the Board of Directors, as further disclosed in the Company’s Current Report on Form 8-K filed by the Company with the Securities and Exchange Commission on May 11, 2023. The comparative periods have been amended and restated to correct for such misstatements. More detailed information related to the amendment and restatement is contained in Amendment No. 1 to the Company’s Annual Report on Form 10-K for the fiscal year ended October 1, 2022 and Amendment No. 1 to the Company’s Form 10-Q for the quarter ended December 31, 2022 as filed with the Securities and Exchange Commission on May 22, 2023. During the preparation of its unaudited consolidated financial statements for the fiscal quarter ended April 1, 2023, the Company determined that certain personnel in one of its divisions had failed to properly substantiate and update cost estimates for materials and other costs over the life of certain contracts. As a result, the Company conducted an independent investigation (the “Investigation”) under the direction of the Audit Committee of the Company’s Board of Directors (the “Audit Committee”). The division, like other Company divisions, has a stand-alone finance organization, which reports directly to the Company’s finance organization and indirectly to the management of the division. References in the findings below refer solely to this division unless otherwise noted. The Investigation found that: • In connection with the preparation and review of quarterly contract cost and other estimates, an internal control in the Company’s accounting process for the division’s contracts with customers, certain division personnel made inappropriate and unsupported adjustments to reduce certain cost estimates and failed to appropriately evaluate and increase other cost estimates to reflect cost overruns and other costs associated with delays in completing certain contracts. • The division had a culture that did not recognize or emphasize the importance of rigor in the division’s quarterly contract estimate review process or its significance to the Company’s internal control over financial reporting and accounting and financial reporting determinations with respect to the division’s contracts with customers. Instead, the division’s tone at the top and other control weaknesses enabled participants in the quarterly contract estimate review process to tolerate, place undue reliance on or otherwise fail to challenge unsupported adjustments and assumptions to contract cost estimates that had been made based on unsubstantiated optimism and/or a desire to avoid adverse outcomes. • The division had an ineffective finance function that did not provide sufficient oversight on financial accounting and reporting matters or effectively challenge adjustments or other improper practices in the quarterly contract estimate review process. • Certain division personnel lacked sufficient understanding of the division’s policies and procedures for the quarterly contract estimate review process as well as the relevant cost and contract accounting practices and requirements. • Certain division personnel provided materially inaccurate and incomplete information to, including in response to inquiries from, Company management and the Company’s internal and independent auditors concerning contract cost estimates and related items. The “Previously Reported” amounts in the following tables are amounts derived from the Form 10-Q for the period ended July 2, 2022. The amounts in columns labeled “Investigation Adjustments” represent the effect of adjustments resulting from an independent investigation conducted by the Audit Committee of the Board of Directors and the amounts in columns labeled “Other Adjustments” represent the effect of uncorrected misstatements in previously filed financial statements that were not material, individually or in the aggregate, to those previously filed financial statements. The effects of the restatement, including the related income tax effects, have been corrected in all impacted tables and footnotes throughout these condensed consolidated financial statements. The only impact to the Unaudited Condensed Consolidated Statements of Comprehensive Income and Unaudited Condensed Consolidated Statements of Stockholders’ Equity was to net income. Investigation Adjustments correct misstatements that resulted primarily from 1) increases to estimated costs at completion of a contract that previously did not properly reflect estimated costs remaining to be incurred to complete a contract, 2) reductions in the amount of transaction consideration expected to be received under a contract, and 3) segmentation of contracts that had previously been combined. The adjustments primarily affected net sales, cost of sales, contract assets and inventory. Other Adjustments primarily correct balance sheet misstatements related to inventory cut-off and advance payments from customers. The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Income for the three and nine months ended July 2, 2022. Three Months Ended Nine Months Ended July 2, 2022 July 2, 2022 (Unaudited) (Unaudited) Previously Reported Investigation Adjustments As Restated Previously Reported Investigation Adjustments As Restated (In thousands, except per share data) Net sales $ 2,019,059 $ 4,302 $ 2,023,361 $ 5,687,914 $ 6,843 $ 5,694,757 Cost of sales 1,853,870 7,306 1,861,176 5,225,789 18,991 5,244,780 Gross profit 165,189 (3,004) 162,185 462,125 (12,148) 449,977 Operating expenses: Selling, general and administrative 61,506 — 61,506 184,798 — 184,798 Research and development 5,071 — 5,071 15,320 — 15,320 Restructuring and other 3,994 — 3,994 3,730 — 3,730 Total operating expenses 70,571 — 70,571 203,848 — 203,848 Operating income 94,618 (3,004) 91,614 258,277 (12,148) 246,129 Interest income 540 — 540 1,198 — 1,198 Interest expense (5,615) — (5,615) (15,362) — (15,362) Other income (expense), net (7,774) — (7,774) (7,110) — (7,110) Interest and other, net (12,849) — (12,849) (21,274) — (21,274) Income before income taxes 81,769 (3,004) 78,765 237,003 (12,148) 224,855 Provision for income taxes 2,226 (683) 1,543 45,606 (2,771) 42,835 Net Income $ 79,543 $ (2,321) $ 77,222 $ 191,397 $ (9,377) $ 182,020 Net income per share: Basic $ 1.33 $ (0.04) $ 1.29 $ 3.07 $ (0.15) $ 2.92 Diluted $ 1.29 $ (0.04) $ 1.25 $ 2.98 $ (0.15) $ 2.83 Weighted average shares used in computing per share amounts: Basic 59,970 — 59,970 62,404 — 62,404 Diluted 61,702 — 61,702 64,292 — 64,292 The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Balance Sheet as of October 1, 2022. As of October 1, 2022 Previously Reported Investigation Adjustments Other Adjustments As Restated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 529,857 $ — $ — $ 529,857 Accounts receivable, net of allowances 1,138,894 — — 1,138,894 Contract assets 503,674 (27,953) — 475,721 Inventories 1,691,081 (21,705) 14,723 1,684,099 Prepaid expenses and other current assets 62,044 — — 62,044 Total current assets 3,925,550 (49,658) 14,723 3,890,615 Property, plant and equipment, net 575,170 — — 575,170 Deferred tax assets 198,588 10,966 — 209,554 Other 160,192 — — 160,192 Total assets $ 4,859,500 $ (38,692) $ 14,723 $ 4,835,531 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,029,534 $ — $ 11,900 $ 2,041,434 Accrued liabilities 275,735 1,441 4,423 281,599 Accrued payroll and related benefits 130,892 — — 130,892 Short-term debt, including current portion of long-term debt 17,500 — — 17,500 Total current liabilities 2,453,661 1,441 16,323 2,471,425 Long-term liabilities: Long-term debt 329,237 — — 329,237 Other 215,333 — — 215,333 Total long-term liabilities 544,570 — — 544,570 Contingencies (Note 8) Stockholders’ equity 1,861,269 (40,133) (1,600) 1,819,536 Total liabilities and stockholders’ equity $ 4,859,500 $ (38,692) $ 14,723 $ 4,835,531 Nine Months Ended July 2, 2022 (Unaudited) Previously Reported Investigation Adjustments Other Adjustments As Restated CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 191,397 $ (9,377) $ — $ 182,020 Adjustments to reconcile net income to cash provided by (used in) operating activities: Depreciation and amortization 82,097 — — 82,097 Stock-based compensation expense 29,045 — — 29,045 Deferred income taxes 18,522 (2,529) — 15,993 Other, net (1,298) — — (1,298) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable (39,850) — (426) (40,276) Contract assets (110,565) 6,210 (8,251) (112,606) Inventories (559,118) 6,544 (277) (552,851) Prepaid expenses and other assets (13,269) — — (13,269) Accounts payable 507,632 — 277 507,909 Accrued liabilities 144,363 (848) 8,677 152,192 Cash provided by operating activities $ 248,956 $ — $ — $ 248,956

Note 2 Basis of Presentation

Note 2 Basis of Presentation	9 Months Ended
	Jul. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]	Basis of Presentation The accompanying condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted pursuant to those rules or regulations. The interim condensed consolidated financial statements are unaudited, but reflect all adjustments, consisting primarily of normal recurring adjustments, that are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended October 1, 2022, included in Amendment No. 1 on Form 10-K/A to the Company’s Annual Report on Form 10-K for such fiscal year filed with the SEC on May 22, 2023. The condensed consolidated financial statements include all accounts of the Company, its wholly-owned subsidiaries and subsidiaries in which it has control. All intra-company accounts and transactions have been eliminated. Noncontrolling interest represents a noncontrolling investor’s interest in the results of operations of subsidiaries that the Company controls and consolidates. The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. Results of operations for the third quarter of 2023 are not necessarily indicative of the results that may be expected for other interim periods or for the full fiscal year.

Note 3 Revenue Recognition

Note 3 Revenue Recognition	9 Months Ended
	Jul. 01, 2023
Revenue from Contract with Customer [Abstract]
Revenue from Contract with Customer [Text Block]	Revenue Recognition The Company is a leading global provider of integrated manufacturing solutions, components, products and repair, logistics and after-market services. For purposes of determining when to recognize revenue, and in what amount, the Company applies a 5-step model: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to the performance obligations in the contract; and (5) recognize revenue when (or as) the Company satisfies a performance obligation. Each of these steps may involve the use of significant judgments, as discussed below. Step 1 - Identify the Contract with a Customer A contract is defined as an agreement between two parties that creates enforceable rights and obligations. The Company generally enters into a master supply agreement (“MSA”) with its customers that provides the framework under which business will be conducted, and pursuant to which a customer will issue purchase orders or other binding documents to specify the quantity, price and delivery requirements for products or services the customer wishes to purchase. The Company generally considers its contract with a customer to be a firm commitment, consisting of the combination of an MSA and a purchase order or any other similar binding document. Step 2 - Identify the Performance Obligations in the Contract A performance obligation is a promised good or service that is material in the context of the contract and is both capable of being distinct (customer can benefit from the good or service on its own or together with other readily available resources) and distinct within the context of the contract (separately identifiable from other promises). The Company reviews its contracts to identify promised goods or services and then evaluates such items to determine which of those items are performance obligations. The majority of the Company’s contracts have a single performance obligation since the promise to transfer an individual good or service is not separately identifiable from other promises in the contract. The Company’s performance obligations generally have an expected duration of one year or less. Step 3 - Determine the Transaction Price The Company’s contracts with its customers may include certain forms of variable consideration such as early payment discounts, volume discounts and shared cost savings. The Company includes an estimate of variable consideration when determining the transaction price and the appropriate amount of revenue to be recognized. This estimate is limited to an amount which will not result in a significant reversal of revenue in a future period. Factors considered in the Company’s estimate of variable consideration are the potential amount subject to these contract provisions, historical experience and other relevant facts and circumstances. Step 4 - Allocate the Transaction Price to the Performance Obligations in the Contract A contract’s transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, the performance obligation is satisfied. In the event that more than one performance obligation is identified in a contract, the Company is required to allocate a portion of the transaction price to each performance obligation. This allocation would generally be based on the relative standalone price of each performance obligation, which most often would represent the price at which the Company would sell similar goods or services separately. Step 5 - Recognize Revenue When (or as) a Performance Obligation is Satisfied The Company is required to assess whether control of a product or services promised under a contract is transferred to the customer at a point-in-time or over time as the product is being manufactured or the services are being provided. If the criteria in ASC 606 for recognizing revenue on an over time basis are not met, revenue must be recognized at the point-in-time determined by the Company at which its customer obtains control of a product or service. The Company has determined that revenue for the majority of its contracts is required to be recognized on an over time basis. This determination is based on the fact that 1) the Company does not have an alternative use for the end products it manufactures for its customers and has an enforceable right to payment, including a reasonable profit, for work-in-progress upon a customer’s cancellation of a contract for convenience or 2) the Company’s customer simultaneously receives and consumes the benefits provided by the Company’s services. For these contracts, revenue is recognized on an over time basis using the cost-to-cost method (ratio of costs incurred to date to total estimated costs at completion) which the Company believes best depicts the transfer of control to the customer. At least 94% of the Company’s revenue is recognized on an over time basis, which is as products are manufactured or services are performed. Because of this, and the fact that there is no work-in-process or finished goods inventory associated with contracts for which revenue is recognized on an over-time basis, 99% or more of the Company’s inventory at the end of a given period is in the form of raw materials. For contracts for which revenue is required to be recognized at a point-in-time, the Company recognizes revenue when it has transferred control of the related goods, which generally occurs upon shipment or delivery of the goods to the customer. Application of the cost-to-cost method for government contracts in the Company’s Defense and Aerospace division requires the use of significant judgments with respect to estimated materials, labor and subcontractor costs included in the total estimated costs at completion. Additionally, the Company evaluates whether contract modifications for claims have been approved and, if so, estimates the amount, if any, of variable consideration that can be included in the transaction price of the contract. This division is an operating segment whose results are combined with eleven other operating segments and reported under Components, Products and Services (“CPS”) for segment reporting purposes. During the nine months ended July 1, 2023, CPS revenue and gross profit were $1 billion and $155 million, respectively. Estimates of materials, labor and subcontractor costs expected to be incurred to satisfy a performance obligation are updated on a quarterly basis. These estimates consider costs incurred to date and estimated costs to be incurred over the remaining expected period of performance to satisfy a performance obligation. Such estimates are reviewed each quarter by a group of employees that includes representatives from numerous functions such as engineering, materials, contracts, manufacturing, program management, finance and senior management. If a change in estimate is deemed necessary, the impact of the change is recognized in the period of change. Additionally, contract modifications for claims are assessed each quarter to determine whether the claims have been approved. If it is determined that a claim has been approved, the amount of the claim, if any, that can be included in transaction price is estimated considering a number of factors such as the length of time expected to lapse until uncertainty about the claim has been resolved and the extent to which our experience with claims for similar contracts has predictive value. Contract Assets A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice to its customer for payment. Contract assets are classified separately on the condensed consolidated balance sheets and transferred to accounts receivable when rights to payment become unconditional. Because of the Company’s short manufacturing cycle times, the transfer from contract assets to accounts receivable generally occurs within the next fiscal quarter. Other Taxes assessed by governmental authorities that are both imposed on and concurrent with a specific revenue-producing transaction, and are collected by the Company from a customer, are excluded from revenue. Shipping and handling costs associated with outbound freight after control of a product has transferred to a customer are accounted for as fulfillment costs and are included in cost of sales. The Company applies the following practical expedients or policy elections under ASC 606: • The promised amount of consideration under a contract is not adjusted for the effects of a significant financing component because, at inception of a contract, the Company expects the period between when a good or service is transferred to a customer and when the customer pays for that good or service will generally be one year or less. • The Company has elected not to disclose information about remaining performance obligations that have original expected durations of one year or less, which is substantially all of the Company’s remaining performance obligations. • Incremental costs of obtaining a contract are not capitalized if the period over which such costs would be amortized to expense is less than one year. Disaggregation of Revenue In the following table, revenue is disaggregated by segment, market sector and geography. Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands) Segments: IMS $ 1,811,530 $ 1,617,858 $ 5,657,800 $ 4,584,185 CPS 395,588 405,503 1,225,229 1,110,572 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 End Markets: Industrial, Defense, Medical and Automotive $ 1,344,068 $ 1,221,989 $ 4,045,939 $ 3,434,221 Communications Networks and Cloud Infrastructure 863,050 801,372 2,837,090 2,260,536 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 Geography: Americas (1) $ 1,131,925 $ 989,172 $ 3,380,454 $ 2,687,304 APAC 743,372 739,084 2,511,205 2,144,534 EMEA 331,821 295,105 991,370 862,919 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 (1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively.

Note 4 Financial Instruments

Note 4 Financial Instruments	9 Months Ended
	Jul. 01, 2023
Financial Instruments [Abstract]
Derivatives and Fair Value [Text Block]	Financial Instruments Fair Value Measurements Fair Value of Financial Instruments The fair values of cash equivalents (represents 23% of cash and cash equivalents), accounts receivable, accounts payable and short-term debt approximate carrying values due to the short-term duration of these instruments. Additionally, the fair value of variable rate long-term debt approximates carrying value as of July 1, 2023. Assets and Liabilities Measured at Fair Value on a Recurring Basis The Company’s primary financial assets and financial liabilities measured at fair value on a recurring basis are deferred compensation plan assets and defined benefit plan assets, which are both measured using Level 1 inputs. Deferred compensation plan assets were $40 million and $37 million as of July 1, 2023 and October 1, 2022, respectively. Defined benefit plan assets were $17 million as of October 1, 2022 and are measured at fair value only in the fourth quarter of each year. Other financial assets and financial liabilities measured at fair value on a recurring basis include foreign exchange contracts and interest rate swaps, which are both measured using Level 2 inputs. Foreign exchange contracts were not material as of July 1, 2023 or October 1, 2022. Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis Other non-financial assets, such as goodwill and other long-lived assets, are measured at fair value as of the date such assets are acquired or in the period an impairment is recorded. Offsetting Derivative Assets and Liabilities The Company has entered into master netting arrangements with each of its derivative counterparties that allows net settlement of derivative assets and liabilities under certain conditions, such as multiple transactions with the same currency maturing on the same date. The Company presents its derivative assets and derivative liabilities on a gross basis on the condensed consolidated balance sheets. The amount that the Company had the right to offset under these netting arrangements was not material as of July 1, 2023 or October 1, 2022. Derivative Instruments Foreign Exchange Rate Risk The Company is exposed to certain risks related to its ongoing business operations. The primary risk managed by using derivative instruments is foreign currency exchange risk. Forward contracts on various foreign currencies are used to manage foreign currency risk associated with forecasted foreign currency transactions and certain monetary assets and liabilities denominated in non-functional currencies. The Company’s primary foreign currency cash flows are in China, Mexico and India. The Company had the following outstanding foreign currency forward contracts that were entered into to hedge foreign currency exposures: As of July 1, October 1, Derivatives Designated as Accounting Hedges: Notional amount (in thousands) $ 127,484 $ 123,172 Number of contracts 50 50 Derivatives Not Designated as Accounting Hedges: Notional amount (in thousands) $ 407,290 $ 531,558 Number of contracts 43 43 The Company utilizes foreign currency forward contracts to hedge certain operational (“cash flow”) exposures resulting from changes in foreign currency exchange rates. Such exposures generally result from (1) forecasted non-functional currency sales and (2) forecasted non-functional currency materials, labor, overhead and other expenses. These contracts are designated as cash flow hedges for accounting purposes and are generally one to two months in duration but, by policy, may be up to twelve months in duration. For derivative instruments that are designated and qualify as cash flow hedges, the Company excludes time value from its assessment of hedge effectiveness and recognizes the amount of time value in earnings over the life of the derivative instrument. Gains or losses on the derivative not caused by changes in time value are recorded in Accumulated Other Comprehensive Income (“AOCI”), a component of equity, and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. The amount of gain or loss recognized in Other Comprehensive Income on derivative instruments and the amount of gain or loss reclassified from AOCI into income were not material for any period presented herein. The Company enters into short-term foreign currency forward contracts to hedge currency exposures associated with certain monetary assets and liabilities denominated in non-functional currencies. These contracts have maturities of up to two months and are not designated as accounting hedges. Accordingly, these contracts are marked-to-market at the end of each period with unrealized gains and losses recorded in other expense, in the condensed consolidated statements of income. The amount of gains or losses associated with these forward contracts was not material for any period presented herein. From an economic perspective, the objective of the Company’s hedging program is for gains and losses on forward contracts to substantially offset gains and losses on the underlying hedged items. In addition to the contracts disclosed in the table above, the Company has numerous contracts that have been closed from an economic and financial accounting perspective and will settle early in the first month of the following quarter. Since these offsetting contracts do not expose the Company to risk of fluctuations in exchange rates, these contracts have been excluded from the above table. Interest Rate Risk The Company enters into forward interest rate swap agreements with independent counterparties to partially hedge the variability in cash flows due to changes in the Secured Overnight Financing Rate (“SOFR”), which is the benchmark interest rate associated with anticipated variable rate borrowings. These interest rate swaps have maturity dates of December 1, 2023 and September 27, 2027 and effectively convert a portion of the Company’s variable interest rate obligations to fixed interest rate obligations. These swaps are accounted for as cash flow hedges under ASC Topic 815, Derivatives and Hedging . Interest rate swaps with an aggregate notional amount of $650 million and $350 million were outstanding as of July 1, 2023 and October 1, 2022, respectively. The aggregate effective interest rate of these swaps as of July 1, 2023 was approximately 4.6%. The interest rate swaps portfolio had a value of $10 million and $6 million as of July 1, 2023 and October 1, 2022, respectively, of which the majority is included in prepaid expenses and other current assets and the remaining amount is included in other long-term liabilities on the condensed consolidated balance sheets.

Note 5 Debt

Note 5 Debt	9 Months Ended
	Jul. 01, 2023
Debt Disclosure [Abstract]
Debt Disclosure [Text Block]	Debt Long-term debt consisted of the following: As of July 1, October 1, (In thousands) Term loan due 2027, net of issuance costs $ 334,052 $ 346,737 Less: Current portion of Term Loan 17,500 17,500 Long-term debt $ 316,552 $ 329,237 Term Loan maturities by fiscal year are as follows: As of July 1, (In thousands) Remainder of 2023 $ 4,375 2024 13,125 2025 17,500 2026 21,875 2027 280,000 $ 336,875 Revolving Credit Facility During the fourth quarter of 2022, the Company entered into a Fifth Amended and Restated Credit Agreement (the “Credit Agreement”), that provides for an $800 million revolving credit facility and drew a $350 million secured term loan (“Term Loan Due 2027”). Subject to the satisfaction of certain conditions, including obtaining additional commitments from existing and/or new lenders, the Company may increase the revolving commitment up to an additional $200 million. Loans under the Credit Agreement bear interest, at the Company's option, at either the SOFR or a base rate, in each case plus a spread determined based on the Company's credit rating. Interest on the loans is payable quarterly in arrears with respect to base rate loans and at the end of an interest period (or at three-month intervals if the interest period exceeds three months) in the case of SOFR loans. The outstanding principal amount of all loans under the Credit Agreement, including, the Term Loan Due 2027, together with accrued and unpaid interest, is due on September 27, 2027. The Company is required to repay a portion of the principal amount of the Term Loan Due 2027 equal to 1.25% of the principal in quarterly installments. On May 17, 2023, as a result of the Company’s failure to timely file its Form 10-Q for the quarter ended April 1, 2023, the Company was in technical default with respect to certain covenants within its Credit Agreement. The Company filed the Form 10-Q on May 22, 2023 within the stated cure period of 15 calendar days and was no longer in default. Certain of the Company’s domestic subsidiaries are guarantors under the Credit Agreement. The Company and the subsidiary guarantors’ obligations under the Credit Agreement are secured by a lien on substantially all of their respective assets (excluding real property), including cash, accounts receivable and the shares of certain Company subsidiaries, subject to certain exceptions. As of July 1, 2023, there were no borrowings and $13 million of letters of credit outstanding under the Credit Agreement. Foreign Short-term Borrowing Facilities As of July 1, 2023, certain foreign subsidiaries of the Company had a total of $73 million of uncommitted short-term borrowing facilities available, under which no borrowings were outstanding. Debt Covenants The Credit Agreement requires the Company to comply with certain financial covenants, namely a maximum consolidated leverage ratio and a minimum interest coverage ratio, in both cases measured on the basis of a trailing 12-month look-back period. In addition, the Company’s debt agreements contain a number of restrictive covenants, including restrictions on incurring additional debt, making investments and other restricted payments, selling assets and paying dividends, subject to certain exceptions. The Company was in compliance with these covenants as of July 1, 2023.

Note 6 Leases

Note 6 Leases	9 Months Ended
	Jul. 01, 2023
Leases [Abstract]
Lessee, Operating Leases	Leases The Company’s leases consist primarily of operating leases for buildings and land and have initial lease terms of up to 44 years. Certain of these leases contain an option to extend the lease term for additional periods or to terminate the lease after an initial non-cancelable term. Renewal options are considered in the measurement of the Company’s initial lease liability and corresponding right-of-use (“ROU”) assets only if it is reasonably certain that the Company will exercise such options. Leases with lease terms of twelve months or less are not recorded on the Company’s balance sheet. ROU assets and lease liabilities are as follows: As of July 1, October 1, (In thousands) Other assets $ 98,288 $ 79,495 Accrued liabilities $ 21,366 $ 16,695 Other long-term liabilities 64,552 48,566 Total lease liabilities $ 85,918 $ 65,261 Weighted average remaining lease term (in years) 10.88 15.74 Weighted average discount rate 3.82 % 2.40 % Lease expense and supplemental cash flow information related to operating leases are as follows: Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (In thousands) Operating lease expense (1) $ 8,976 $ 6,009 $ 26,541 $ 17,779 Nine Months Ended July 1, July 2, (In thousands) Cash paid for operating lease liabilities $ 18,023 $ 14,566 (1) Includes immaterial amounts of short-term leases, variable lease costs and sublease income. Future lease payments under non-cancelable operating leases as of July 1, 2023, by fiscal year, are as follows: Operating Leases (In thousands) Remainder of 2023 $ 6,187 2024 23,998 2025 21,258 2026 16,876 2027 13,624 Thereafter 13,113 Total lease payments 95,056 Less: imputed interest 9,138 Total $ 85,918

Note 7 Accounts Receivable Sale

Note 7 Accounts Receivable Sale Program	9 Months Ended
	Jul. 01, 2023
Transfers and Servicing [Abstract]
Transfers and Servicing of Financial Assets [Text Block]	Accounts Receivable Sale Program The Company is a party to a Receivable Purchase Agreement (the “RPA”) with certain third-party banking institutions for the sale of trade receivables generated from sales to certain customers, subject to acceptance by, and a funding commitment from, the banks that are party to the RPA. Trade receivables sold pursuant to the RPA are serviced by the Company. In addition to the RPA, the Company has the option to participate in trade receivables sales programs that have been implemented by certain of the Company’s customers, as in effect from time to time. The Company does not service trade receivables sold under these other programs. Under each of the programs noted above, the Company sells its entire interest in a trade receivable for 100% of face value, less a discount. During the nine months ended July 1, 2023 and July 2, 2022, the Company sold approximately $2 billion and $1 billion, respectively, of accounts receivable under these programs. Upon sale, these receivables are removed from the condensed consolidated balance sheets and cash received is presented as cash provided by operating activities in the condensed consolidated statements of cash flows. Discounts on sold receivables were $16 million and $2 million for the nine months ended July 1, 2023 and July 2, 2022, respectively. As of July 1, 2023 and October 1, 2022, $172 million and $194 million, respectively, of accounts receivable sold under the RPA and subject to servicing by the Company remained outstanding and had not yet been collected. The Company’s sole risk with respect to receivables it services, is with respect to commercial disputes regarding such receivables. Commercial disputes include billing errors, returns and similar matters. To date, the Company has not been required to repurchase any receivable it has sold due to a commercial dispute. Additionally, the Company is required to remit amounts collected as the servicer under the RPA on a weekly basis to the financial institutions that purchased the receivables. As of July 1, 2023 and October 1, 2022, $58 million and $49 million, respectively, had been collected but not yet remitted. This amount is classified in accrued liabilities on the condensed consolidated balance sheets.

Note 8 Commitments and Continge

Note 8 Commitments and Contingencies	9 Months Ended
	Jul. 01, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Text Block]	Contingencies From time to time, the Company is a party to litigation, claims and other contingencies, including environmental, regulatory and employee matters and examinations and investigations by governmental agencies, which arise in the ordinary course of business. The Company records a contingent liability when it is probable that a loss has been incurred and the amount of loss is reasonably estimable in accordance with ASC Topic 450, Contingencies, or other applicable accounting standards. As of July 1, 2023 and October 1, 2022, the Company had estimated liabilities of $34 million and $38 million, respectively, for environmental matters, warranty, litigation and other contingencies (excluding reserves for uncertain tax positions), which the Company believes are adequate. However, there can be no assurance that the Company’s reserves will be sufficient to settle these contingencies. Such reserves are included in accrued liabilities and other long-term liabilities on the condensed consolidated balance sheets. Legal Proceedings Environmental Matters The Company is subject to various federal, state, local and foreign laws and regulations and administrative orders concerning environmental protection, including those addressing the discharge of pollutants into the environment, the management and disposal of hazardous substances, the cleanup of contaminated sites, the materials used in products, and the recycling, treatment and disposal of hazardous waste. As of July 1, 2023, the Company had been named in a lawsuit and several administrative orders alleging that certain of its current and former sites sent waste for disposal that contributed to groundwater contamination, which require further management and care. One such order demands that the Company and other alleged defendants, fund continued post-closure care and remediation at four properly permitted former hazardous waste landfills located in Northern California to which the Company may have sent wastewater in the past. The Company is participating with a working group of a number of other alleged defendants in a pending settlement of this matter and has reserved its estimated exposure for this matter as of July 1, 2023, which amount is immaterial. In June 2008, the Company was named by the Orange County Water District in a suit alleging that a predecessor company’s actions at a plant the Company sold in 1998 contributed to polluted groundwater managed by the plaintiff. The complaint seeks recovery of compensatory and other damages, as well as declaratory relief, for the payment of costs necessary to investigate, monitor, remediate, abate and contain contamination of groundwater. In April 2013, all claims against the Company were dismissed. The plaintiff appealed this dismissal and the Court of Appeal reversed the judgment in August 2017, remanding the case back to the Superior Court of California for trial. The trial against the Company and several other defendants commenced in April 2021 and the submission of evidence concluded in May 2022. On April 3, 2023, the Court published a statement of decision finding the Company and other remaining defendants liable for certain past investigation costs incurred by the plaintiff. The Company believes a loss in this matter is probable and has recorded its estimated loss as of July 1, 2023. There will be subsequent proceedings to assess the Company’s and other defendants’ liability for the plaintiff’s future remediation and other costs, including attorneys’ fees. It is probable that the Company will record additional losses in connection with this matter, and it is reasonably possible that the amount of such additional losses will be material. However, the Company is unable to estimate the amount of such additional losses or a range of losses. The Company intends to continue defending the case vigorously and to seek appellate review at the appropriate time. Other Matters In December 2019, the Company sued a former customer, Dialight plc (“Dialight”), in the United States District Court for the Southern District of New York to collect approximately $10 million in unpaid accounts receivable and net obsolete inventory obligations. Later the same day, Dialight commenced its own action in the same court. Dialight’s complaint, which asserts claims for fraudulent inducement, breach of contract and willful misconduct, alleges that the Company fraudulently misrepresented its capabilities to induce Dialight to enter into a Manufacturing Services Agreement (the “Dialight MSA”), and then breached its obligations contained in the Dialight MSA relating to quality, on-time delivery and supply chain management. Dialight seeks compensatory and punitive damages that it contends exceed $200 million, but the Company believes Dialight’s claimed damages are vastly overstated and are subject to a contractual limitation of liability that limits any Dialight recovery to less than $2 million. In an Opinion and Order dated March 14, 2023, the Court granted in part the Company’s motion for partial summary judgment and dismissed Dialight’s willful misconduct claim. The Company continues to vigorously prosecute its claims against Dialight. Further, the Company strongly disagrees with Dialight’s allegations and is defending against Dialight’s remaining claims vigorously. No trial date has been set in this matter. In May 2023, the Company and its SCI Technology, Inc. subsidiary (“SCI”) received Civil Investigative Demands (“CIDs”) from the United States Department of Justice (“DOJ") pursuant to the civil False Claims Act (“FCA”). The stated purpose of the CIDs—a form of subpoena requiring responses to written interrogatories and the production of documents relating to certain contracts, projects, proposals and business activities of SCI going back to 2010—is to determine whether there is or has been a violation of the FCA with respect to the provision of products and services to the government. These CIDs supplement several CIDs relating to the same subject matter served upon SCI and certain current and former SCI and Sanmina employees beginning in August 2020, pursuant to which SCI has been producing documents and information and the current and former employees have provided or will provide oral testimony. To date, neither the Company nor SCI has been served with a complaint in this matter. The Company has been, and is, cooperating with the DOJ and continues to produce documents and other information responsive to the CIDs. The Company is unable to predict the ultimate outcome in this matter, although a loss currently is not considered to be probable or estimable. For each of the pending matters noted above, the Company is unable to reasonably estimate a range of possible loss at this time. In addition, from time to time, the Company may become involved in routine legal proceedings, demands, claims, threatened litigation and regulatory inquiries and investigations that arise in the normal course of our business. The Company records liabilities for such matters when a loss becomes probable and the amount of loss can be reasonably estimated. The ultimate outcome of any litigation is uncertain and unfavorable outcomes could have a negative impact on the Company’s results of operations and financial condition.

Note 9 Income Tax

Note 9 Income Tax	9 Months Ended
	Jul. 01, 2023
Income Tax Disclosure [Abstract]
Income Tax Disclosure [Text Block]	Income Tax The Company estimates its annual effective income tax rate at the end of each quarterly period. The estimate takes into account the geographic mix of expected pre-tax income (loss), expected total annual pre-tax income (loss), enacted changes in tax laws, implementation of tax planning strategies and possible outcomes of audits and other uncertain tax positions. To the extent there are fluctuations in any of these variables during a period, the provision for income taxes may vary. The Company’s provision for income taxes for the three months ended July 1, 2023 and July 2, 2022 was $17 million (17% of income before taxes) and $2 million (2% of income before taxes), respectively. I ncome tax expense for the three months ended July 1, 2023 and July 2, 20 22 included the recognition of ta x benefits of approximately $5 million and $15 million, respectively, that resulted from the release of certain foreign tax reserves due to lapse of time and expiration of statutes of limitations. The Company’s provision for income taxes for the nine months ended July 1, 2023 and July 2, 2022 was $64 million (20% of income before taxes) and $43 million (19% of income before taxes), respectively. Income tax expense was higher for the nine months ended July 1, 2023 primarily due to an increase in profit before tax.

Note 10 Stockholders' Equity

Note 10 Stockholders' Equity	9 Months Ended
	Jul. 01, 2023
Stockholders' Equity Note [Abstract]
Stockholders' Equity Note Disclosure [Text Block]	Stockholders’ Equity Accumulated Other Comprehensive Income Accumulated other comprehensive income, net of tax as applicable, consisted of the following: As of July 1, October 1, (In thousands) Foreign currency translation adjustments $ 70,736 $ 63,929 Unrealized holding gains on derivative financial instruments 7,044 4,112 Unrecognized net actuarial losses and transition costs for benefit plans (11,898) (11,716) Total $ 65,882 $ 56,325 Stock Repurchase Program During the nine months ended July 1, 2023 and July 2, 2022, the Company repurchased 1 million and 7 million shares of its common stock for $51 million and $293 million, respectively, under stock repurchase programs authorized by the Board of Directors. These programs have no expiration dates and the timing of repurchases will depend upon capital needs to support the growth of the Company’s business, market conditions and other factors. Although stock repurchases are intended to increase stockholder value, they also reduce the Company’s liquidity. During the third quarter of 2023, the Company’s Board of Directors authorized the repurchase of up to $200 million of the Company’s common stock in the open market or in negotiated private transactions. As of July 1, 2023, an aggregate of $312 million remained available under these programs. In addition to the repurchases discussed above, the Company withheld 0.4 million and 0.4 million shares of its common stock during the nine months ended July 1, 2023 and July 2, 2022, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock units. The Company paid $22 million and $13 million for the nine months ended July 1, 2023 and July 2, 2022, respectively, to applicable tax authorities in connection with these repurchases.

Note 11 Business Segment, Geogr

Note 11 Business Segment, Geographic and Customer Information	9 Months Ended
	Jul. 01, 2023
Segment Reporting [Abstract]
Segment Reporting Disclosure [Text Block]	Business Segment, Geographic and Customer Information ASC Topic 280, Segment Reporting , establishes standards for reporting information about operating segments, products and services, geographic areas of operations and major customers. Operating segments are defined as components of an enterprise for which separate financial information is available and evaluated regularly by the chief operating decision maker or decision-making group in deciding how to allocate resources and in assessing performance. The Company’s operations are managed as two businesses: Integrated Manufacturing Solutions (“IMS”) and CPS. The Company’s CPS business consists of multiple operating segments which do not meet the quantitative threshold for being presented individually as reportable segments. Therefore, financial information for these operating segments is presented in a single category entitled “CPS” and the Company has only one reportable segment - IMS. The following table presents revenue and a measure of segment gross profit used by management to allocate resources and assess performance of operating segments: Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands) Gross sales: IMS $ 1,821,819 $ 1,624,760 $ 5,689,432 $ 4,607,895 CPS 419,156 432,058 1,308,326 1,191,743 Intersegment revenue (33,857) (33,457) (114,729) (104,881) Net sales $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 Gross profit: IMS $ 152,059 $ 118,359 $ 429,855 $ 333,648 CPS 37,036 47,801 154,564 128,393 Total 189,095 166,160 584,419 462,041 Unallocated items (1) (5,887) (3,975) (14,636) (12,064) Total $ 183,208 $ 162,185 $ 569,783 $ 449,977 (1) For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, litigation settlements and investigation costs. Net sales by geographic segment, determined based on the country in which a product is manufactured, were as follows: Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands) Net sales: Americas (1) $ 1,131,925 $ 989,172 $ 3,380,454 $ 2,687,304 APAC 743,372 739,084 2,511,205 2,144,534 EMEA 331,821 295,105 991,370 862,919 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 (1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively. Percentage of net sales represented by ten largest customers 47 % 48 % 49 % 49 % Number of customers representing 10% or more of net sales 1 1 1 2

Note 12 Earnings Per Share

Note 12 Earnings Per Share	9 Months Ended
	Jul. 01, 2023
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Earnings Per Share Basic and diluted per share amounts are calculated by dividing net income attributable to common shareholders by the weighted average number of shares of common stock outstanding during the period, as follows: Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands, except per share data) Numerator: Net income attributable to common shareholders $ 76,494 $ 77,222 $ 248,129 $ 182,020 Denominator: Weighted average common shares outstanding 57,987 59,970 57,995 62,404 Effect of dilutive stock options and restricted stock units 1,605 1,732 2,001 1,888 Denominator for diluted earnings per share 59,592 61,702 59,996 64,292 Net income attributable to common shareholders per share: Basic $ 1.32 $ 1.29 $ 4.28 $ 2.92 Diluted $ 1.28 $ 1.25 $ 4.14 $ 2.83 Weighted-average dilutive securities that were excluded from the above calculation because their inclusion would have had an anti-dilutive effect under ASC Topic 260, Earnings per Share , due to application of the treasury stock method were not material for any period presented.

Note 13 Stock-Based Compensatio

Note 13 Stock-Based Compensation	9 Months Ended
	Jul. 01, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Share-based Payment Arrangement [Text Block]	Stock-Based Compensation Stock-based compensation expense was recognized as follows: Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (In thousands) Cost of sales $ 4,518 $ 3,724 $ 12,785 $ 10,455 Selling, general and administrative 8,588 6,819 24,034 18,230 Research and development 211 140 641 360 Total $ 13,317 $ 10,683 $ 37,460 $ 29,045 During the second quarter of 2023, the Company's stockholders approved the reservation of an additional 1 million shares of common stock for future issuance under the Company's 2019 Equity Incentive Plan. As of July 1, 2023, an aggregate of 6 million shares of common stock were authorized for future issuance under the Company’s stock plans, of which 3 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 3 million shares of common stock were available for future grant. Restricted and Performance Stock Units The Company grants restricted stock units (“RSUs”) and restricted stock units with performance conditions (“PSUs”) to executive officers, directors and certain other employees. These units vest over periods ranging from one year to four years and/or upon achievement of specified performance criteria, with associated compensation expense recognized ratably over the vesting period. Generally, the Company’s PSUs vest contingent on achievement of cumulative non-GAAP earnings per share measured over three fiscal years. If a minimum threshold is not achieved during the measurement period, the PSUs will be cancelled. If the minimum threshold is achieved or exceeded, the number of shares of common stock that will be issued will range from 70% to 130% of the number of PSUs granted, depending on the extent of performance. Additionally, the number of shares that vest may be adjusted up or down by up to 15% based on the Company’s total shareholder return relative to that of its peer group over this same period. Activity with respect to the Company’s RSUs and PSUs was as follows: Number of Weighted- Weighted- Aggregate (In thousands) (In thousands) Outstanding as of October 1, 2022 3,280 37.11 1.35 155,049 Granted 952 59.88 Vested/Forfeited/Cancelled (1,309) 36.09 Outstanding as of July 1, 2023 2,923 44.98 1.38 172,287 Expected to vest as of July 1, 2023 2,592 44.51 1.33 152,789

Note 14 Strategic Transactions

Note 14 Strategic Transactions	9 Months Ended
	Jul. 01, 2023
Business Combination and Asset Acquisition [Abstract]
Business Combination Disclosure	Strategic Transaction India Joint Venture On October 3, 2022 (“Transaction Date”), the Company completed a joint venture transaction pursuant to a Share Subscription and Purchase Agreement (the “SSPA”) and a Joint Venture and Shareholders’ Agreement (the “Shareholders’ Agreement”) previously entered into with Reliance Strategic Business Ventures Limited (“RSBVL”), a wholly owned subsidiary of Reliance Industries Limited. Pursuant to the SSPA and the Shareholders’ Agreement, the parties established Sanmina SCI India Private Limited (“SIPL”), the Company’s existing Indian manufacturing entity, as a joint venture to engage in manufacturing in India of telecommunications equipment, data center and internet equipment, medical equipment, clean technology equipment and other high-tech equipment. This partnership leverages the Company’s advanced manufacturing experience and RSBVL’s expertise and leadership in the Indian business ecosystem. In addition to supporting the Company’s current customer base, the joint venture will create a state-of-the-art ‘Manufacturing Technology Center of Excellence’ that will serve as an incubation center to support the product development and hardware start-up ecosystem in India, as well as promote research and innovation of leading-edge technologies. As a result of the transaction, RSBVL acquired shares of SIPL for approximately $216 million of cash such that RSBVL holds 50.1% of the outstanding shares of SIPL and the Company holds the remaining 49.9% of the outstanding shares of SIPL. In connection with RSBVL’s investment, the Company and RSBVL entered into a management services contract pursuant to which the Company has the unilateral ability to make the significant financial and operating decisions made in the ordinary course of SIPL’s business. In accordance with ASC 810, Consolidation , the Company is required to consolidate entities in which it has a controlling financial interest. The Company determined the voting interest model was applicable under ASC 810 and concluded that, despite not having a majority ownership interest, the Company has a controlling financial interest in SIPL through the management services contract. Therefore, the Company has, by contract, the unilateral ability to control the significant decisions made in the ordinary course of SIPL’s business. Because the Company has a controlling financial interest in SIPL, it consolidates SIPL. However, the Company periodically assesses whether any changes in facts and circumstances have occurred that could require the Company to deconsolidate SIPL. The Company recognized a noncontrolling interest of $132 million and an increase in additional paid-in-capital of $84 million in the condensed consolidated financial statements in connection with the sale of shares of SIPL to RSBVL as of the Transaction Date. SIPL’s cash and cash equivalents balance of $167 million as of July 1, 2023 is not available for general corporate purposes and must be retained in SIPL to fund SIPL’s operations.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Pay vs Performance Disclosure
Net income attributable to common shareholders	$ 76,494	$ 77,222	$ 248,129	$ 182,020

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended	9 Months Ended
	Jul. 01, 2023 shares	Jul. 01, 2023 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	During our last fiscal quarter, the following director adopted a “Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408, as follows: On May 30, 2023, David V. Hedley III, a member of the Board of Directors of the Company, adopted a Rule 10b5-1 trading arrangement (the “Plan”) with respect to the sale of 1,574 shares of common stock to cover income tax liabilities associated with the vesting of director RSUs during the term of the Plan. The Plan terminates on May 30, 2024 or at such time all shares under the Plan are sold and is intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) under the Securities Exchange Act of 1934, as amended. No other directors or officers, as defined in Rule 16a-1(f), adopted and/or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” as defined in Regulation S-K Item 408, during the last fiscal quarter.
Name	David V. Hedley III
Title	a member of the Board of Directors
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	May 30, 2023
Termination Date		May 30, 2024
Aggregate Available	1,574	1,574

Accounting Policies (Policies)

Accounting Policies (Policies)	9 Months Ended
	Jul. 01, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Accounting [Text Block]	The accompanying condensed consolidated financial statements of the Company have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted pursuant to those rules or regulations. The interim condensed consolidated financial statements are unaudited, but reflect all adjustments, consisting primarily of normal recurring adjustments, that are, in the opinion of management, necessary to a fair statement of the results for the interim periods presented. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto for the year ended October 1, 2022, included in Amendment No. 1 on Form 10-K/A to the Company’s Annual Report on Form 10-K for such fiscal year filed with the SEC on May 22, 2023.The condensed consolidated financial statements include all accounts of the Company, its wholly-owned subsidiaries and subsidiaries in which it has control. All intra-company accounts and transactions have been eliminated. Noncontrolling interest represents a noncontrolling investor’s interest in the results of operations of subsidiaries that the Company controls and consolidates.
Use of Estimates, Policy [Policy Text Block]	The preparation of financial statements requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. Results of operations for the third quarter of 2023 are not necessarily indicative of the results that may be expected for other interim periods or for the full fiscal year.
Fiscal Period, Policy [Policy Text Block]	The Company operates on a 52 or 53 week year ending on the Saturday nearest September 30. Fiscal 2023 and 2022 are each 52-week years. All references to years relate to fiscal years unless otherwise noted.

Note 1. Restatement of Conden_2

Note 1. Restatement of Condensed Consolidated Financial Statements (Tables)	9 Months Ended
	Jul. 01, 2023
Accounting Changes and Error Corrections [Abstract]
Schedule of Error Corrections and Prior Period Adjustments	The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Statements of Income for the three and nine months ended July 2, 2022. Three Months Ended Nine Months Ended July 2, 2022 July 2, 2022 (Unaudited) (Unaudited) Previously Reported Investigation Adjustments As Restated Previously Reported Investigation Adjustments As Restated (In thousands, except per share data) Net sales $ 2,019,059 $ 4,302 $ 2,023,361 $ 5,687,914 $ 6,843 $ 5,694,757 Cost of sales 1,853,870 7,306 1,861,176 5,225,789 18,991 5,244,780 Gross profit 165,189 (3,004) 162,185 462,125 (12,148) 449,977 Operating expenses: Selling, general and administrative 61,506 — 61,506 184,798 — 184,798 Research and development 5,071 — 5,071 15,320 — 15,320 Restructuring and other 3,994 — 3,994 3,730 — 3,730 Total operating expenses 70,571 — 70,571 203,848 — 203,848 Operating income 94,618 (3,004) 91,614 258,277 (12,148) 246,129 Interest income 540 — 540 1,198 — 1,198 Interest expense (5,615) — (5,615) (15,362) — (15,362) Other income (expense), net (7,774) — (7,774) (7,110) — (7,110) Interest and other, net (12,849) — (12,849) (21,274) — (21,274) Income before income taxes 81,769 (3,004) 78,765 237,003 (12,148) 224,855 Provision for income taxes 2,226 (683) 1,543 45,606 (2,771) 42,835 Net Income $ 79,543 $ (2,321) $ 77,222 $ 191,397 $ (9,377) $ 182,020 Net income per share: Basic $ 1.33 $ (0.04) $ 1.29 $ 3.07 $ (0.15) $ 2.92 Diluted $ 1.29 $ (0.04) $ 1.25 $ 2.98 $ (0.15) $ 2.83 Weighted average shares used in computing per share amounts: Basic 59,970 — 59,970 62,404 — 62,404 Diluted 61,702 — 61,702 64,292 — 64,292 The following table presents the impact of the financial statement adjustments on the Company’s previously reported Condensed Consolidated Balance Sheet as of October 1, 2022. As of October 1, 2022 Previously Reported Investigation Adjustments Other Adjustments As Restated (In thousands) ASSETS Current assets: Cash and cash equivalents $ 529,857 $ — $ — $ 529,857 Accounts receivable, net of allowances 1,138,894 — — 1,138,894 Contract assets 503,674 (27,953) — 475,721 Inventories 1,691,081 (21,705) 14,723 1,684,099 Prepaid expenses and other current assets 62,044 — — 62,044 Total current assets 3,925,550 (49,658) 14,723 3,890,615 Property, plant and equipment, net 575,170 — — 575,170 Deferred tax assets 198,588 10,966 — 209,554 Other 160,192 — — 160,192 Total assets $ 4,859,500 $ (38,692) $ 14,723 $ 4,835,531 LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities: Accounts payable $ 2,029,534 $ — $ 11,900 $ 2,041,434 Accrued liabilities 275,735 1,441 4,423 281,599 Accrued payroll and related benefits 130,892 — — 130,892 Short-term debt, including current portion of long-term debt 17,500 — — 17,500 Total current liabilities 2,453,661 1,441 16,323 2,471,425 Long-term liabilities: Long-term debt 329,237 — — 329,237 Other 215,333 — — 215,333 Total long-term liabilities 544,570 — — 544,570 Contingencies (Note 8) Stockholders’ equity 1,861,269 (40,133) (1,600) 1,819,536 Total liabilities and stockholders’ equity $ 4,859,500 $ (38,692) $ 14,723 $ 4,835,531 Nine Months Ended July 2, 2022 (Unaudited) Previously Reported Investigation Adjustments Other Adjustments As Restated CASH FLOWS PROVIDED BY (USED IN) OPERATING ACTIVITIES: Net income $ 191,397 $ (9,377) $ — $ 182,020 Adjustments to reconcile net income to cash provided by (used in) operating activities: Depreciation and amortization 82,097 — — 82,097 Stock-based compensation expense 29,045 — — 29,045 Deferred income taxes 18,522 (2,529) — 15,993 Other, net (1,298) — — (1,298) Changes in operating assets and liabilities, net of amounts acquired: Accounts receivable (39,850) — (426) (40,276) Contract assets (110,565) 6,210 (8,251) (112,606) Inventories (559,118) 6,544 (277) (552,851) Prepaid expenses and other assets (13,269) — — (13,269) Accounts payable 507,632 — 277 507,909 Accrued liabilities 144,363 (848) 8,677 152,192 Cash provided by operating activities $ 248,956 $ — $ — $ 248,956

Note 3 Revenue Recognition (Tab

Note 3 Revenue Recognition (Tables)	9 Months Ended
	Jul. 01, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue [Table Text Block]	Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands) Segments: IMS $ 1,811,530 $ 1,617,858 $ 5,657,800 $ 4,584,185 CPS 395,588 405,503 1,225,229 1,110,572 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 End Markets: Industrial, Defense, Medical and Automotive $ 1,344,068 $ 1,221,989 $ 4,045,939 $ 3,434,221 Communications Networks and Cloud Infrastructure 863,050 801,372 2,837,090 2,260,536 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 Geography: Americas (1) $ 1,131,925 $ 989,172 $ 3,380,454 $ 2,687,304 APAC 743,372 739,084 2,511,205 2,144,534 EMEA 331,821 295,105 991,370 862,919 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 (1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively.

Note 4 Derivative Financial Ins

Note 4 Derivative Financial Instruments (Tables)	9 Months Ended
	Jul. 01, 2023
Financial Instruments [Abstract]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	As of July 1, October 1, Derivatives Designated as Accounting Hedges: Notional amount (in thousands) $ 127,484 $ 123,172 Number of contracts 50 50 Derivatives Not Designated as Accounting Hedges: Notional amount (in thousands) $ 407,290 $ 531,558 Number of contracts 43 43

Note 5 Debt (Tables)

Note 5 Debt (Tables)	9 Months Ended
	Jul. 01, 2023
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments [Table Text Block]	As of July 1, October 1, (In thousands) Term loan due 2027, net of issuance costs $ 334,052 $ 346,737 Less: Current portion of Term Loan 17,500 17,500 Long-term debt $ 316,552 $ 329,237
Schedule of Maturities of Long-Term Debt [Table Text Block]	As of July 1, (In thousands) Remainder of 2023 $ 4,375 2024 13,125 2025 17,500 2026 21,875 2027 280,000 $ 336,875

Note 6 Leases (Tables)

Note 6 Leases (Tables)	9 Months Ended
	Jul. 01, 2023
Leases [Abstract]
Asset and Liabilities, Lessee [Table Text Block]	As of July 1, October 1, (In thousands) Other assets $ 98,288 $ 79,495 Accrued liabilities $ 21,366 $ 16,695 Other long-term liabilities 64,552 48,566 Total lease liabilities $ 85,918 $ 65,261 Weighted average remaining lease term (in years) 10.88 15.74 Weighted average discount rate 3.82 % 2.40 %
Lease, Cost [Table Text Block]	Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (In thousands) Operating lease expense (1) $ 8,976 $ 6,009 $ 26,541 $ 17,779 Nine Months Ended July 1, July 2, (In thousands) Cash paid for operating lease liabilities $ 18,023 $ 14,566 (1) Includes immaterial amounts of short-term leases, variable lease costs and sublease income.
Lessee, Operating Lease, Liability, Maturity [Table Text Block]	Operating Leases (In thousands) Remainder of 2023 $ 6,187 2024 23,998 2025 21,258 2026 16,876 2027 13,624 Thereafter 13,113 Total lease payments 95,056 Less: imputed interest 9,138 Total $ 85,918

Note 10 Stockholders' Equity (T

Note 10 Stockholders' Equity (Tables)	9 Months Ended
	Jul. 01, 2023
Stockholders' Equity Note [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	As of July 1, October 1, (In thousands) Foreign currency translation adjustments $ 70,736 $ 63,929 Unrealized holding gains on derivative financial instruments 7,044 4,112 Unrecognized net actuarial losses and transition costs for benefit plans (11,898) (11,716) Total $ 65,882 $ 56,325

Note 11 Business Segment, Geo_2

Note 11 Business Segment, Geographic and Customer Information (Tables)	9 Months Ended
	Jul. 01, 2023
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands) Gross sales: IMS $ 1,821,819 $ 1,624,760 $ 5,689,432 $ 4,607,895 CPS 419,156 432,058 1,308,326 1,191,743 Intersegment revenue (33,857) (33,457) (114,729) (104,881) Net sales $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 Gross profit: IMS $ 152,059 $ 118,359 $ 429,855 $ 333,648 CPS 37,036 47,801 154,564 128,393 Total 189,095 166,160 584,419 462,041 Unallocated items (1) (5,887) (3,975) (14,636) (12,064) Total $ 183,208 $ 162,185 $ 569,783 $ 449,977 (1) For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, litigation settlements and investigation costs.
Schedule of Revenue from External Customers by Geographic Area [Table Text Block]	Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands) Net sales: Americas (1) $ 1,131,925 $ 989,172 $ 3,380,454 $ 2,687,304 APAC 743,372 739,084 2,511,205 2,144,534 EMEA 331,821 295,105 991,370 862,919 Total $ 2,207,118 $ 2,023,361 $ 6,883,029 $ 5,694,757 (1) Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively. Percentage of net sales represented by ten largest customers 47 % 48 % 49 % 49 % Number of customers representing 10% or more of net sales 1 1 1 2

Note 12 Earnings Per Share (Tab

Note 12 Earnings Per Share (Tables)	9 Months Ended
	Jul. 01, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (Restated) (Restated) (In thousands, except per share data) Numerator: Net income attributable to common shareholders $ 76,494 $ 77,222 $ 248,129 $ 182,020 Denominator: Weighted average common shares outstanding 57,987 59,970 57,995 62,404 Effect of dilutive stock options and restricted stock units 1,605 1,732 2,001 1,888 Denominator for diluted earnings per share 59,592 61,702 59,996 64,292 Net income attributable to common shareholders per share: Basic $ 1.32 $ 1.29 $ 4.28 $ 2.92 Diluted $ 1.28 $ 1.25 $ 4.14 $ 2.83 Weighted-average dilutive securities that were excluded from the above calculation because their inclusion would have had an anti-dilutive effect under ASC Topic 260, Earnings per Share , due to application of the treasury stock method were not material for any period presented.

Note 13 Stock-Based Compensat_2

Note 13 Stock-Based Compensation (Tables)	9 Months Ended
	Jul. 01, 2023
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]	Three Months Ended Nine Months Ended July 1, July 2, July 1, July 2, (In thousands) Cost of sales $ 4,518 $ 3,724 $ 12,785 $ 10,455 Selling, general and administrative 8,588 6,819 24,034 18,230 Research and development 211 140 641 360 Total $ 13,317 $ 10,683 $ 37,460 $ 29,045
Schedule of Restricted Stock Units Award Activity [Table Text Block]	Number of Weighted- Weighted- Aggregate (In thousands) (In thousands) Outstanding as of October 1, 2022 3,280 37.11 1.35 155,049 Granted 952 59.88 Vested/Forfeited/Cancelled (1,309) 36.09 Outstanding as of July 1, 2023 2,923 44.98 1.38 172,287 Expected to vest as of July 1, 2023 2,592 44.51 1.33 152,789

Note 1. Restatement of Conden_3

Note 1. Restatement of Condensed Consolidated Financial Statements (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022	Oct. 01, 2022
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales	$ 2,207,118	$ 2,023,361	$ 6,883,029	$ 5,694,757
Cost of sales	2,023,910	1,861,176	6,313,246	5,244,780
Gross profit	183,208	162,185	569,783	449,977
Selling, general and administrative	68,828	61,506	192,948	184,798
Research and development	6,719	5,071	18,712	15,320
Restructuring and other	296	3,994	1,731	3,730
Operating Expenses	75,843	70,571	213,391	203,848
Operating Income (Loss)	107,365	91,614	356,392	246,129
Interest income	4,213	540	9,685	1,198
Interest expense	(10,066)	(5,615)	(28,033)	(15,362)
Other expense	(2,508)	(7,774)	(11,988)	(7,110)
Nonoperating Income (Expense)	(8,361)	(12,849)	(30,336)	(21,274)
Income before income taxes	99,004	78,765	326,056	224,855
Provision for income taxes	17,267	1,543	63,898	42,835
Net income before noncontrolling interest	$ 81,737	$ 77,222	$ 262,158	$ 182,020
Basic	$ 1.32	$ 1.29	$ 4.28	$ 2.92
Diluted	$ 1.28	$ 1.25	$ 4.14	$ 2.83
Basic	57,987	59,970	57,995	62,404
Diluted	59,592	61,702	59,996	64,292
Cash and cash equivalents	$ 656,588		$ 656,588		$ 529,857
Accounts and Other Receivables, Net, Current	1,279,966		1,279,966		1,138,894
Contract assets	459,145		459,145		475,721
Inventories	1,489,200		1,489,200		1,684,099
Prepaid expenses and other current assets	68,121		68,121		62,044
Assets, Current	3,953,020		3,953,020		3,890,615
Property, plant and equipment, net	631,744		631,744		575,170
Deferred tax assets	187,434		187,434		209,554
Other	185,694		185,694		160,192
Assets	4,957,892		4,957,892		4,835,531
Accounts payable	1,724,034		1,724,034		2,041,434
Accrued liabilities	277,515		277,515		281,599
Accrued payroll and related benefits	138,815		138,815		130,892
Short-term debt, including current portion of long-term debt	17,500		17,500		17,500
Liabilities, Current	2,157,864		2,157,864		2,471,425
Long-term debt	316,552		316,552		329,237
Other	217,748		217,748		215,333
Liabilities, Noncurrent	534,300		534,300		544,570
Stockholders’ equity	2,265,728	$ 1,768,560	2,265,728	$ 1,768,560	1,819,536
Liabilities and Equity	4,957,892		4,957,892		4,835,531
Depreciation and amortization			87,716	82,097
Share-based Payment Arrangement, Noncash Expense	$ 13,317	10,683	37,460	29,045
Deferred income taxes			21,232	15,993
Other, net			284	(1,298)
Accounts receivable			(137,712)	(40,276)
Contract assets			16,576	(112,606)
Inventories			199,406	(552,851)
Prepaid expenses and other assets			(27,492)	(13,269)
Accounts payable			(308,579)	507,909
Accrued liabilities			7,262	152,192
Net Cash Provided by (Used in) Operating Activities			$ 158,311	248,956
Previously Reported
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		2,019,059		5,687,914
Cost of sales		1,853,870		5,225,789
Gross profit		165,189		462,125
Selling, general and administrative		61,506		184,798
Research and development		5,071		15,320
Restructuring and other		3,994		3,730
Operating Expenses		70,571		203,848
Operating Income (Loss)		94,618		258,277
Interest income		540		1,198
Interest expense		(5,615)		(15,362)
Other expense		(7,774)		(7,110)
Nonoperating Income (Expense)		(12,849)		(21,274)
Income before income taxes		81,769		237,003
Provision for income taxes		2,226		45,606
Net income before noncontrolling interest		$ 79,543		$ 191,397
Basic		$ 1.33		$ 3.07
Diluted		$ 1.29		$ 2.98
Basic		59,970		62,404
Diluted		61,702		64,292
Cash and cash equivalents					529,857
Accounts and Other Receivables, Net, Current					1,138,894
Contract assets					503,674
Inventories					1,691,081
Prepaid expenses and other current assets					62,044
Assets, Current					3,925,550
Property, plant and equipment, net					575,170
Deferred tax assets					198,588
Other					160,192
Assets					4,859,500
Accounts payable					2,029,534
Accrued liabilities					275,735
Accrued payroll and related benefits					130,892
Short-term debt, including current portion of long-term debt					17,500
Liabilities, Current					2,453,661
Long-term debt					329,237
Other					215,333
Liabilities, Noncurrent					544,570
Stockholders’ equity					1,861,269
Liabilities and Equity					4,859,500
Depreciation and amortization				$ 82,097
Share-based Payment Arrangement, Noncash Expense				29,045
Deferred income taxes				18,522
Other, net				(1,298)
Accounts receivable				(39,850)
Contract assets				(110,565)
Inventories				(559,118)
Prepaid expenses and other assets				(13,269)
Accounts payable				507,632
Accrued liabilities				144,363
Net Cash Provided by (Used in) Operating Activities				248,956
Restatement Investigation Adjustment Member
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net sales		$ 4,302		6,843
Cost of sales		7,306		18,991
Gross profit		(3,004)		(12,148)
Selling, general and administrative		0		0
Research and development		0		0
Restructuring and other		0		0
Operating Expenses		0		0
Operating Income (Loss)		(3,004)		(12,148)
Interest income		0		0
Interest expense		0		0
Other expense		0		0
Nonoperating Income (Expense)		0		0
Income before income taxes		(3,004)		(12,148)
Provision for income taxes		(683)		(2,771)
Net income before noncontrolling interest		$ (2,321)		$ (9,377)
Basic		$ (0.04)		$ (0.15)
Diluted		$ (0.04)		$ (0.15)
Basic		0		0
Diluted		0		0
Cash and cash equivalents					0
Accounts and Other Receivables, Net, Current					0
Contract assets					(27,953)
Inventories					(21,705)
Prepaid expenses and other current assets					0
Assets, Current					(49,658)
Property, plant and equipment, net					0
Deferred tax assets					10,966
Other					0
Assets					(38,692)
Accounts payable					0
Accrued liabilities					1,441
Accrued payroll and related benefits					0
Short-term debt, including current portion of long-term debt					0
Liabilities, Current					1,441
Long-term debt					0
Other					0
Liabilities, Noncurrent					0
Stockholders’ equity					(40,133)
Liabilities and Equity					(38,692)
Depreciation and amortization				$ 0
Share-based Payment Arrangement, Noncash Expense				0
Deferred income taxes				(2,529)
Other, net				0
Accounts receivable				0
Contract assets				6,210
Inventories				6,544
Prepaid expenses and other assets				0
Accounts payable				0
Accrued liabilities				(848)
Net Cash Provided by (Used in) Operating Activities				0
Restatement Other Adjustment Member
Error Corrections and Prior Period Adjustments Restatement [Line Items]
Net income before noncontrolling interest				0
Cash and cash equivalents					0
Accounts and Other Receivables, Net, Current					0
Contract assets					0
Inventories					14,723
Prepaid expenses and other current assets					0
Assets, Current					14,723
Property, plant and equipment, net					0
Deferred tax assets					0
Other					0
Assets					14,723
Accounts payable					11,900
Accrued liabilities					4,423
Accrued payroll and related benefits					0
Short-term debt, including current portion of long-term debt					0
Liabilities, Current					16,323
Long-term debt					0
Other					0
Liabilities, Noncurrent					0
Stockholders’ equity					(1,600)
Liabilities and Equity					$ 14,723
Depreciation and amortization				0
Share-based Payment Arrangement, Noncash Expense				0
Deferred income taxes				0
Other, net				0
Accounts receivable				(426)
Contract assets				(8,251)
Inventories				(277)
Prepaid expenses and other assets				0
Accounts payable				277
Accrued liabilities				8,677
Net Cash Provided by (Used in) Operating Activities				$ 0

Note 3 Disagregation of Revenue

Note 3 Disagregation of Revenue (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Disaggregation of Revenue [Line Items]
Percent of Net Sales Transferred Over Time				94%
Raw Materials, net of reserves, as a percentage of total Inventory		99%		99%
Number of Other Operating Segment Excluding DAS				11
Net sales		$ 2,207,118	$ 2,023,361	$ 6,883,029	$ 5,694,757
Gross profit		183,208	162,185	569,783	449,977
Operating Segments
Disaggregation of Revenue [Line Items]
Gross profit		189,095	166,160	584,419	462,041
Americas
Disaggregation of Revenue [Line Items]
Net sales	[1]	1,131,925	989,172	3,380,454	2,687,304
Asia Pacific
Disaggregation of Revenue [Line Items]
Net sales		743,372	739,084	2,511,205	2,144,534
EMEA
Disaggregation of Revenue [Line Items]
Net sales		331,821	295,105	$ 991,370	$ 862,919
Mexico
Disaggregation of Revenue [Line Items]
Percentage of Net Sales to Americas Net Sales				70%	60%
United States
Disaggregation of Revenue [Line Items]
Percentage of Net Sales to Americas Net Sales				30%	40%
Industrial, Defense, Medical and Automotive
Disaggregation of Revenue [Line Items]
Net sales		1,344,068	1,221,989	$ 4,045,939	$ 3,434,221
Communications Networks and Cloud Infrastructure
Disaggregation of Revenue [Line Items]
Net sales		863,050	801,372	2,837,090	2,260,536
IMS Third Party Revenue
Disaggregation of Revenue [Line Items]
Net sales		1,811,530	1,617,858	5,657,800	4,584,185
CPS Third Party Revenue
Disaggregation of Revenue [Line Items]
Net sales		395,588	405,503	1,225,229	1,110,572
CPS | Operating Segments
Disaggregation of Revenue [Line Items]
Net sales		419,156	432,058	1,308,326	1,191,743
Gross profit		$ 37,036	$ 47,801	$ 154,564	$ 128,393
[1]Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively.

Note 4 Fair Value (Details)

Note 4 Fair Value (Details) - USD ($) $ in Millions	9 Months Ended
	Jul. 01, 2023	Oct. 01, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash Equivalents	23%
Fair Value, Inputs, Level 1 [Member] | Fair Value, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets for Plan Benefits, Defined Benefit Plan		$ 17
Deferred Compensation Plan Assets	$ 40	37
Fair Value, Inputs, Level 2 [Member] | Fair Value, Recurring [Member] | Derivatives Designated as Accounting Hedges: | Interest Rate Swap [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Interest Rate Cash Flow Hedge Asset at Fair Value	$ 10	$ 6

Note 4 Derivatives (Details)

Note 4 Derivatives (Details) $ in Thousands	9 Months Ended
	Jul. 01, 2023 USD ($)	Oct. 01, 2022 USD ($)
Derivatives Designated as Accounting Hedges: | Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 127,484	$ 123,172
Number of contracts	50	50
Maximum Length of Time Hedged	12 months
Derivatives Designated as Accounting Hedges: | Interest Rate Swap [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 650,000	$ 350,000
Effective Interest Rate	4.60%
Derivatives Designated as Accounting Hedges: | Interest Rate Swap [Member] | $350M Aggregate Notional Value of Swaps
Derivative [Line Items]
Maturity Date	Dec. 01, 2023
Derivatives Designated as Accounting Hedges: | Interest Rate Swap [Member] | $300M Aggregate Notional Value of Swaps [Member]
Derivative [Line Items]
Maturity Date	Sep. 27, 2027
Derivatives Not Designated as Accounting Hedges: | Foreign Exchange Forward [Member]
Derivative [Line Items]
Derivative, Notional Amount	$ 407,290	$ 531,558
Number of contracts	43	43
Maximum Remaining Maturity	2 months

Note 5 Debt Schedule (Details)

Note 5 Debt Schedule (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Debt Instrument [Line Items]
Long-term debt	$ 316,552	$ 329,237
Term Loan Due 2027
Debt Instrument [Line Items]
Term loan due 2027, net of issuance costs	334,052	346,737
Less: Current portion of Term Loan	17,500	$ 17,500
Long-term Debt, Fiscal Year Maturity [Abstract]
Remainder of Fiscal Year	4,375
Long-Term Debt, Maturity, Year One	13,125
Long-Term Debt, Maturity, Year Two	17,500
Long-Term Debt, Maturty, Year Three	21,875
Repayments of Principal in Year Four	280,000
Long-term Debt, Gross	$ 336,875

Note 5 Line of Credit Facility

Note 5 Line of Credit Facility (Details) $ in Millions	3 Months Ended
	Jul. 01, 2023 USD ($)
Foreign Line of Credit
Line of Credit Facility [Line Items]
Maximum Borrowing Capacity	$ 73
Long-term Line of Credit	0
Fifth Amended and Restated Credit Agreement
Line of Credit Facility [Line Items]
Maximum Borrowing Capacity	800
Long-term Line of Credit	0
Letters of Credit Outstanding, Amount	13
Term Loan	350
Additional Credit Line	$ 200
Line of Credit Facility, Expiration Date	Sep. 27, 2027
Term Loan Due 2027 | Fifth Amended and Restated Credit Agreement
Line of Credit Facility [Line Items]
Repayment Percentage for Long-term Debt	1.25%

Note 6 Lessee Lease Description

Note 6 Lessee Lease Description (Details)	Jul. 01, 2023
Maximum [Member]
Lessee, Lease, Description [Line Items]
Term of Contract	44 years

Note 6 Leases (Detail)

Note 6 Leases (Detail) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Leases [Abstract]
Operating Lease, Right-of-Use Asset	$ 98,288	$ 79,495
Operating Lease, Liability, Current	21,366	16,695
Operating Lease, Liability, Noncurrent	64,552	48,566
Operating Lease, Liability	$ 85,918	$ 65,261
Operating Lease, Weighted Average Remaining Lease Term	10 years 10 months 17 days	15 years 8 months 26 days
Operating Lease, Weighted Average Discount Rate, Percent	3.82%	2.40%
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other	Other
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued liabilities	Accrued liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other	Other
Operating Lease, Liability, Statement of Financial Position [Extensible Enumeration]	Liabilities, Total [Member]	Liabilities, Total [Member]

Note 6 Lease Cost (Details)

Note 6 Lease Cost (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Leases [Abstract]
Operating Leases, Rent Expense, Net	[1]	$ 8,976	$ 6,009	$ 26,541	$ 17,779
Operating Lease, Payments				$ 18,023	$ 14,566
[1]Includes immaterial amounts of short-term leases, variable lease costs and sublease income.

Note 6 Future Lease Liability (

Note 6 Future Lease Liability (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year	$ 6,187
Lessee, Operating Lease, Liability, to be Paid, Year One	23,998
Lessee, Operating Lease, Liability, to be Paid, Year Two	21,258
Lessee, Operating Lease, Liability, to be Paid, Year Three	16,876
Lessee, Operating Lease, Liability, to be Paid, Year Four	13,624
Lessee, Operating Lease, Liability, to be Paid, after Year Five	13,113
Lessee, Operating Lease, Liability, to be Paid	95,056
Lessee, Operating Lease, Liability, Undiscounted Excess Amount	9,138
Operating Lease, Liability	$ 85,918	$ 65,261

Note 7 Accounts Receivable Sa_2

Note 7 Accounts Receivable Sale Program (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Oct. 01, 2022
Transfer of Financial Assets Accounted for as Sales [Line Items]
Face Value of Receivable Sold, Percentage	100%
Accounts Receivable Sold During The Period	$ 2,000,000	$ 1,000,000
Discount on sold receivables	16,000	$ 2,000
RPA [Member]
Transfer of Financial Assets Accounted for as Sales [Line Items]
Accounts Receivable Sold and Outstanding	172,000		$ 194,000
Amount Collected But Not Remitted to Financial Institutions	$ 58,000		$ 49,000

Note 8 Contingencies (Details)

Note 8 Contingencies (Details) - USD ($) $ in Thousands	9 Months Ended
	Jul. 01, 2023	Oct. 01, 2022
Loss Contingencies [Line Items]
Loss Contingency Accrual	$ 34,000	$ 38,000
Collectibility of Receivable and Excess and Obsolete Inventory [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	10,000
Performance of Manufacturing Service Agreement
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	200,000
Performance of Manufacturing Service Agreement | Maximum [Member]
Loss Contingencies [Line Items]
Loss Contingency, Estimate of Possible Loss	$ 2,000

Note 9 Income Tax (Details)

Note 9 Income Tax (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 17,267	$ 1,543	$ 63,898	$ 42,835
Effective Income Tax Rate	17%	2%	20%	19%
Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations	$ 5,000	$ 15,000

Note 10 Stockholders' Equity (D

Note 10 Stockholders' Equity (Details) - USD ($) $ in Thousands	Jul. 01, 2023	Oct. 01, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign currency translation adjustments	$ 70,736	$ 63,929
AOCI, Cash Flow Hedge, Cumulative Gain (Loss), after Tax	7,044	4,112
Unrecognized net actuarial losses and transition costs for benefit plans	(11,898)	(11,716)
Total	$ 65,882	$ 56,325

Note 10 Stock Repurchase (Detai

Note 10 Stock Repurchase (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 01, 2023	Jul. 01, 2023	Jul. 02, 2022
Stockholders' Equity Note [Abstract]
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 312,000	$ 312,000
Shares Repurchased		1,000,000	7,000,000
Cash Paid for Share Repurchases		$ 51,000	$ 293,000
Stock Repurchase Program Additional Authorized Amount	$ 200,000
Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation		400,000	400,000
Amount of Tax Withholding for Share-based Compensation		$ 22,000	$ 13,000

Note 11 Revenue and Gross Profi

Note 11 Revenue and Gross Profit by Segment (Details) $ in Thousands		3 Months Ended		9 Months Ended
		Jul. 01, 2023 USD ($)	Jul. 02, 2022 USD ($)	Jul. 01, 2023 USD ($)	Jul. 02, 2022 USD ($)
Segment Reporting Information [Line Items]
Net sales		$ 2,207,118	$ 2,023,361	$ 6,883,029	$ 5,694,757
Gross profit		183,208	162,185	$ 569,783	449,977
Number of Reportable Segments				1
Operating Segments
Segment Reporting Information [Line Items]
Gross profit		189,095	166,160	$ 584,419	462,041
Operating Segments | IMS
Segment Reporting Information [Line Items]
Net sales		1,821,819	1,624,760	5,689,432	4,607,895
Gross profit		152,059	118,359	429,855	333,648
Operating Segments | CPS
Segment Reporting Information [Line Items]
Net sales		419,156	432,058	1,308,326	1,191,743
Gross profit		37,036	47,801	154,564	128,393
Intersegment revenue
Segment Reporting Information [Line Items]
Net sales		(33,857)	(33,457)	(114,729)	(104,881)
Unallocated items
Segment Reporting Information [Line Items]
Gross profit	[1]	$ (5,887)	$ (3,975)	$ (14,636)	$ (12,064)
[1]For purposes of evaluating segment performance, management excludes certain items from its measure of gross profit. These items consist of stock-based compensation expense, amortization of intangible assets, litigation settlements and investigation costs.

Note 11 Segment Reporting by Ge

Note 11 Segment Reporting by Geographic Segment (Details) - USD ($) $ in Thousands		3 Months Ended		9 Months Ended
		Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Revenue from External Customer [Line Items]
Net sales		$ 2,207,118	$ 2,023,361	$ 6,883,029	$ 5,694,757
Percentage of net sales represented by ten largest customers		47%	48%	49%	49%
Number of customers representing 10% or more of net sales		1	1	1	2
Americas
Revenue from External Customer [Line Items]
Net sales	[1]	$ 1,131,925	$ 989,172	$ 3,380,454	$ 2,687,304
Asia Pacific
Revenue from External Customer [Line Items]
Net sales		743,372	739,084	2,511,205	2,144,534
EMEA
Revenue from External Customer [Line Items]
Net sales		$ 331,821	$ 295,105	$ 991,370	$ 862,919
Mexico
Revenue from External Customer [Line Items]
Percentage of Net Sales to Americas Net Sales				70%	60%
United States
Revenue from External Customer [Line Items]
Percentage of Net Sales to Americas Net Sales				30%	40%
[1]Mexico represents approximately 70% and 60% of the Americas revenue and the U.S. represents approximately 30% and 40% of the Americas revenue for the nine months ended July 1, 2023 and July 2, 2022, respectively.

Note 12 Earnings Per Share (Det

Note 12 Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Weighted average shares used in computing per share amount:
Net income attributable to common shareholders	$ 76,494	$ 77,222	$ 248,129	$ 182,020
Weighted average common shares outstanding	57,987	59,970	57,995	62,404
Effect of dilutive stock options and restricted stock units	1,605	1,732	2,001	1,888
Denominator for diluted earnings per share	59,592	61,702	59,996	64,292
Net income attributable to common shareholders per share:
Basic	$ 1.32	$ 1.29	$ 4.28	$ 2.92
Net income attributable to common shareholders per share:
Diluted	$ 1.28	$ 1.25	$ 4.14	$ 2.83

Note 13 Share-Based Compensatio

Note 13 Share-Based Compensation Arrangements (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Allocation of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Noncash Expense	$ 13,317	$ 10,683	$ 37,460	$ 29,045
Cost of sales
Allocation of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	4,518	3,724	12,785	10,455
Selling, general and administrative
Allocation of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	8,588	6,819	24,034	18,230
Research and development
Allocation of Recognized Period Costs [Line Items]
Share-based Payment Arrangement, Expense	$ 211	$ 140	$ 641	$ 360

Note 13 Shares Authorized for F

Note 13 Shares Authorized for Future Issuance and Available for Grant (Details) shares in Thousands	3 Months Ended
	Jul. 01, 2023 shares
Share-Based Payment Arrangement, Additional Disclosure [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	1,000
Common Stock, Capital Shares Reserved for Future Issuance	6,000
Stock options and unvested restricted stock units outstanding	3,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	3,000

Note 13 Additional Information

Note 13 Additional Information (Details)	9 Months Ended
	Jul. 01, 2023
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting Period	1 year
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting Period	4 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Potential adjustment to PSUs	15%
Performance Shares | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Potential Payout Percentage	70%
Performance Shares | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Potential Payout Percentage	130%

Note 13 Restricted Stock Rollfo

Note 13 Restricted Stock Rollforward (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	9 Months Ended	12 Months Ended
	Jul. 01, 2023	Oct. 01, 2022
Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Outstanding, beginning	3,280
Granted	952
Vested/Forfeited/Cancelled	(1,309)
Outstanding, ending	2,923	3,280
Expected to vest	2,592
Weighted Average Grant Date Fair Value Restricted Stock [Abstract]
Outstanding, beginning	$ 37.11
Granted	59.88
Vested/Forfeited/Cancelled	36.09
Outstanding, ending	44.98	$ 37.11
Expected to vest	$ 44.51
Weighted Average Remaining Contractual Term [Abstract]
Outstanding	1 year 4 months 17 days	1 year 4 months 6 days
Expected to vest	1 year 3 months 29 days
Restricted Stock Non vested Aggregate Intrinsic Value [Abstract]
Outstanding	$ 172,287	$ 155,049
Expected to vest	$ 152,789

Note 13 Unrecognized Stock Base

Note 13 Unrecognized Stock Based Compensation Expense (Details) $ in Millions	9 Months Ended
	Jul. 01, 2023 USD ($)
Unrecognized Compensation Cost and Weighted Average Period [Line Items]
Unrecognized compensation expense	$ 82
Weighted average period of recognition (years)	1 year 4 months 24 days

Note 14 Strategic Transactions

Note 14 Strategic Transactions (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Jul. 01, 2023	Jul. 01, 2023	Jul. 02, 2022	Oct. 03, 2022	Oct. 01, 2022
Business Acquisition [Line Items]
Proceeds from sale of noncontrolling interest		$ 215,799	$ 0
Cash and cash equivalents	$ 656,588	656,588			$ 529,857
Joint Venture with Reliance [Member]
Business Acquisition [Line Items]
Proceeds from sale of noncontrolling interest	216,000
Noncontrolling Interest in Joint Ventures				$ 132,000
APIC Attributable to Parent from Joint Venture Transaction				$ 84,000
Cash and cash equivalents	$ 167,000	$ 167,000
Joint Venture with Reliance [Member] | RSVL
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired				50.10%
Joint Venture with Reliance [Member] | Sanmina
Business Acquisition [Line Items]
Business Acquisition, Percentage of Voting Interests Acquired				49.90%